Notice of Results
Abingdon Health plc has announced that it will release its interim results for the six months ending 31 December 2025 on Tuesday, 17 March 2026, and will host an investor presentation on the same day at 11:00 GMT via the Investor Meet Company platform.
Select text to share a quote on X · sign in to keep highlights & notes in your ABDX notes
York, U.K. 5 March 2026: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, will announce its interim results for the six months ended 31 December 2025 on Tuesday 17 March 2026.
Investor Presentation
The Company will provide a live online presentation relating to the interim results via the Investor Meet Company platform on Tuesday 17 March 2026 at 11:00 GMT. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 GMT the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Abingdon Health plc via: https://www.investormeetcompany.com/abingdon-health-plc/register-investor
Investors who already follow Abingdon Health plc on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.